Qualitas Health joins industry leaders to address key omega-3 research and developments

Omega-3s: fact, fiction and the future at Nutrition Integrates 2015

Qualitas Health, developers of high-value vegetarian food supplements and pharmaceutical ingredients based on microalgae, has announced that it will participate in an industry panel on omega-3s at the Nutrition Integrates 2015 Conference to be held Thursday 4 June at the Grange Tower Bridge Hotel in London, UK.

The panel discussion is part of the Health Management track at the conference, and is scheduled to take place at 15:35. David Hart, VP of Marketing at Qualitas Health will join other industry panelists from GlaxoSmithKline, the University of Amsterdam, TASA Omega and Croda Healthcare to discuss recent research, industry data, condition-specific claims and alternative forms of omega-3s. The session is to be facilitated by Ellen Schutt, communications director at GOED.

Qualitas Health’s flagship product, Almega PL, provides a sustainable, vegetarian, EPA-rich source of omega-3s from non-GMO microalgae. Its polar lipids (phospholipids and glycolipids) provide a special form of omega-3s with a unique structure that is easier for the body to break down and absorb.

Companies

Related Articles

Related Product News